8-K
Nathalie Bernier Resigns from Bausch + Lomb Corporation Board of Directors
8-K
Bausch + Lomb Reports Strong Q3 2026 Results and Raises Full-Year Guidance
8-K
Bausch + Lomb and Bausch Health Appoint Thomas J. Appio Interim CEO and Expect to Raise Full-Year 2026 Guidance
8-K/A
Board Restructuring Announced with New Chairman and Committee Appointments Effective August 10, 2026.
8-K
Bausch + Lomb Announces Board of Directors Update and Reaffirms 2026 Financial Guidance
8-K
Bausch + Lomb Reports Second-Quarter 2026 Financial Results and Raises Full-Year Guidance
